RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
Abstract Although the survival rate of patients with cancer have increased due to the use of current chemotherapeutic agents, adverse effects of cancer therapy remain a concern. The reversal of drug resistance, reduction in harmful side effects and accelerated increase in efficiency have often been...
Main Authors: | Xiao Tan, Zhongqiang Zhang, Ping Liu, Hongliang Yao, Liangfang Shen, Jing-Shan Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-12-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-020-03266-3 |
Similar Items
-
Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
by: Xiao Tan, et al.
Published: (2023-03-01) -
Retracted: GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF‐κB signaling pathway in colorectal cancer cells
by: Zhongqiang Zhang, et al.
Published: (2018-11-01) -
EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
by: Wang C, et al.
Published: (2023-08-01) -
Retracted: Trastuzumab induces PUMA‐dependent apoptosis and inhibits tumor growth in gastric cancer
by: Linghe Luo, et al.
Published: (2018-12-01) -
Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression
by: Junhui Yu, et al.
Published: (2023-02-01)